Table 5.
Signs and symptoms on study admission in the PP population (n = 105)*
| Signs and symptoms | Cefditoren pivoxil (50) (%) | Cefdinir (55) (%) |
|---|---|---|
| Fever | ||
| Present | 10 (20.00) | 9 (16.36) |
| Absent | 40 (80.00) | 46 (83.64) |
| Chills | ||
| Present | 0 (0) | 1 (1.82) |
| Absent | 50 (100) | 54 (98.18) |
| Malaise | ||
| Present | 6 (12.00) | 3 (5.45) |
| Absent | 44 (88.00) | 52 (94.55) |
| Pruritus | ||
| Present | 11 (22.00) | 18 (32.73) |
| Absent | 39 (78.00) | 37 (67.27) |
| Pain at the site of lesion(s) | ||
| Present | 45 (90.00) | 51 (92.73) |
| Absent | 5 (10.00) | 4 (7.27) |
| Erythema around the lesion(s) | ||
| Present | 44 (88.00) | 50 (90.91) |
| Absent | 6 (12.00) | 5 (9.09) |
| Tenderness | ||
| Present | 48 (96.00) | 51 (92.73) |
| Absent | 2 (4.00) | 4 (7.27) |
| Regional lymphadenopathy | ||
| Present | 10 (20.00) | 12 (21.82) |
| Absent | 40 (80.00) | 43 (78.18) |
| Ulceration of lesion(s) | ||
| Present | 19 (38.00) | 16 (29.09) |
| Absent | 31 (62.00) | 39 (70.91) |
| Discharge from lesion(s) | ||
| Present | 39 (78.00) | 40 (72.73) |
| Absent | 11 (22.00) | 15 (27.27) |
| Crust/Scab formation | ||
| Present | 22 (44.00) | 19 (34.55) |
| Absent | 28 (56.00) | 36 (65.45) |
| Induration | ||
| Present | 21 (42.00) | 23 (41.82) |
| Absent | 29 (58.00) | 32 (58.18) |
*
Data presented as no. of patients with % of patients indicated within the brackets